← Back to headlines
Charles River Laboratories Shares Could Rally on Biotech Rebound
JPMorgan suggests that shares of drug researcher Charles River Laboratories could continue to rally, driven by a resurgence in investments within the biotechnology industry following its recent earnings report.
6 Aug, 13:00 — 6 Aug, 13:00
